search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


To determine the requirement of cysteine in preterm infants with different gestational ages and postnatal age.


- candidate number1425
- NTR NumberNTR245
- ISRCTNISRCTN35832828
- Date ISRCTN created20-dec-2005
- date ISRCTN requested18-okt-2005
- Date Registered NTR7-sep-2005
- Secondary IDsN/A 
- Public TitleTo determine the requirement of cysteine in preterm infants with different gestational ages and postnatal age.
- Scientific TitleCysteine Requirements for Preterm Infants.
- ACRONYMN/A
- hypothesis1. Cysteine is an essential amino acid for newborn preterm infants;
2. Cysteine requirements change rapidly with postnatal age;
3. The change in cysteine requirement with age is based upon cystathionase activity;
4. Intestinal cystathionase activity is of major importance for the conversion of methionine to cysteine.
- Healt Condition(s) or Problem(s) studiedPreterm neonates, Premature infants
- Inclusion criteria1. Infants born with a gestational age of 26-29 weeks will be studied at a post-conceptional age of 30-32 weeks and at a post-conceptional age of 35-37 weeks.
2. Infants born at a gestational age of 32-34 weeks will also be studied at a post-conceptional age of 35-37 weeks.
- Exclusion criteria1. Congenital metabolic disease;
2. Congenital anomalies;
3. Gastroinestinal diseases.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingSingle
- controlActive
- groupCrossover
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2004
- planned closingdate1-jun-2006
- Target number of participants80
- InterventionsInfants receive a testdiets with graded amounts of Cystine for 32 hours.
- Primary outcome1. Fractional oxidation of 13C-phenylalanine;
2. Whole body flux of 13C-phenylalanine.
- Secondary outcomeN/A
- TimepointsN/A
- Trial web siteN/A
- statusstopped: trial finished
- CONTACT FOR PUBLIC QUERIES M.A. Riedijk
- CONTACT for SCIENTIFIC QUERIESProf. MD. PhD. J.B. Goudoever, van
- Sponsor/Initiator Sophia Foundation For Scientific Research (SSWO)
- Funding
(Source(s) of Monetary or Material Support)
Sophia Children’s Hospital Fund
- Publications1. Am J Clin Nutr. 2007 Oct;86(4):1120-5.
2. Pediatrics. 2008 Mar;121(3):e561-7. Epub 2008 Feb 18.
- Brief summaryCysteine is considered to be a conditionally essential amino acid in premature infants. This is due to immaturity of the enzymatic pathway responsible for conversion of methionine to cysteine.
Cysteine plays a key role in glutathione synthesis which is a very important antioxidant. Many complications of premature birth are based upon oxidant damage.
In this study we will investigate the cysteine requirement in premature infants. Infants born with a gestational age of 26-29 weeks will be studied at a post-conceptional age of 30-32 weeks and at a post-conceptional age of 35-37 weeks. Infants born at a gestational age of 32-34 weeks will also be studied at a post-conceptional age of 35-37 weeks. Preterm infants with the above described characteristics regarding postnatal and gestational age will be fed testdiets with graded amounts of cystine. Fractional oxidation will be measured using the Indicator Amino Acid Oxidation method.
- Main changes (audit trail)
- RECORD6-sep-2005 - 18-nov-2008


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl